Aisling Capital Management as of March 31, 2020
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 14 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 50.4 | $116M | 4.0M | 29.00 | |
| Eidos Therapeutics | 24.0 | $55M | 1.1M | 48.99 | |
| Avrobio Ord (AVRO) | 6.8 | $16M | 1.0M | 15.56 | |
| Syndax Pharmaceuticals (SNDX) | 4.2 | $9.6M | 875k | 10.97 | |
| Atreca Inc Cl A (BCEL) | 2.8 | $6.4M | 388k | 16.55 | |
| Aeglea Biotherapeutics | 2.6 | $6.0M | 1.3M | 4.66 | |
| Arcus Biosciences Incorporated (RCUS) | 2.0 | $4.6M | 333k | 13.88 | |
| Sunesis Pharmaceuticals Inc Ne | 1.8 | $4.2M | 10M | 0.41 | |
| Marker Therapeutics Ord | 1.7 | $3.8M | 2.0M | 1.90 | |
| Obseva Sa | 1.5 | $3.3M | 1.4M | 2.41 | |
| Verona Pharma Plc ads (VRNA) | 0.8 | $1.8M | 444k | 4.12 | |
| Zosano Pharma Corp | 0.7 | $1.5M | 2.7M | 0.56 | |
| Nabriva Therapeutics | 0.5 | $1.1M | 1.9M | 0.57 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $660k | 635k | 1.04 |
